A detailed history of Ameritas Investment Partners, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 58,523 shares of EXEL stock, worth $1.95 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
58,523
Previous 61,958 5.54%
Holding current value
$1.95 Million
Previous $1.39 Million 9.05%
% of portfolio
0.05%
Previous 0.05%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$21.96 - $27.6 $75,432 - $94,806
-3,435 Reduced 5.54%
58,523 $1.52 Million
Q2 2024

Aug 13, 2024

SELL
$20.34 - $23.73 $99,686 - $116,300
-4,901 Reduced 7.33%
61,958 $1.39 Million
Q1 2024

May 13, 2024

SELL
$20.17 - $23.93 $36,386 - $43,169
-1,804 Reduced 2.63%
66,859 $1.59 Million
Q4 2023

Feb 14, 2024

SELL
$19.25 - $24.13 $52,783 - $66,164
-2,742 Reduced 3.84%
68,663 $1.65 Million
Q3 2023

Nov 13, 2023

SELL
$19.04 - $22.74 $188,781 - $225,467
-9,915 Reduced 12.19%
71,405 $1.56 Million
Q2 2023

Aug 11, 2023

SELL
$18.17 - $20.48 $26,291 - $29,634
-1,447 Reduced 1.75%
81,320 $1.55 Million
Q3 2022

Nov 14, 2022

SELL
$15.68 - $22.27 $43,433 - $61,687
-2,770 Reduced 3.24%
82,767 $1.3 Million
Q2 2022

Aug 12, 2022

BUY
$17.44 - $23.16 $16,376 - $21,747
939 Added 1.11%
85,537 $1.78 Million
Q4 2021

Feb 11, 2022

BUY
$15.84 - $21.88 $18,120 - $25,030
1,144 Added 1.37%
84,598 $1.55 Million
Q3 2021

Nov 15, 2021

SELL
$16.3 - $21.14 $20,391 - $26,446
-1,251 Reduced 1.48%
83,454 $1.76 Million
Q2 2021

Aug 06, 2021

SELL
$17.95 - $25.56 $18,650 - $26,556
-1,039 Reduced 1.21%
84,705 $1.54 Million
Q4 2020

Feb 12, 2021

SELL
$18.39 - $24.8 $31,888 - $43,003
-1,734 Reduced 1.98%
85,744 $1.72 Million
Q3 2020

Nov 13, 2020

SELL
$20.67 - $26.94 $25,548 - $33,297
-1,236 Reduced 1.39%
87,478 $2.14 Million
Q2 2020

Aug 05, 2020

BUY
$16.46 - $27.42 $50,976 - $84,919
3,097 Added 3.62%
88,714 $2.11 Million
Q3 2019

Nov 14, 2019

SELL
$17.68 - $22.65 $43,298 - $55,469
-2,449 Reduced 2.78%
85,617 $1.51 Million
Q3 2018

Nov 13, 2018

BUY
$15.87 - $22.4 $96,267 - $135,878
6,066 Added 7.4%
88,066 $1.56 Million
Q2 2018

Aug 13, 2018

BUY
$18.56 - $22.45 $1.52 Million - $1.84 Million
82,000 New
82,000 $1.77 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.